NKGEN BIOTECH Trademark

Trademark Overview


On Friday, February 5, 2021, a trademark application was filed for NKGEN BIOTECH with the United States Patent and Trademark Office. The USPTO has given the NKGEN BIOTECH trademark a serial number of 90514320. The federal status of this trademark filing is REGISTERED as of Tuesday, January 17, 2023. This trademark is owned by NKMAX CO., LTD.. The NKGEN BIOTECH trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

pharmaceutical preparations for animals; Pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of cells; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; stem cells for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatmen...

development of cell therapy products; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes; medical and pharmacological research services; medical research services; development of biotechnology; biotechnological research; cell separation research services; technological research in the field of cell therapy, medicine, pharmacology, biotechnology
nkgen biotech

General Information


Serial Number90514320
Word MarkNKGEN BIOTECH
Filing DateFriday, February 5, 2021
Status700 - REGISTERED
Status DateTuesday, January 17, 2023
Registration Number6958359
Registration DateTuesday, January 17, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2021

Trademark Statements


Goods and Servicespharmaceutical preparations for animals; Pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations for the prevention of diseases of the immune system; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of cells; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of inflammatory diseases; stem cells for medical purposes; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of immune system related diseases and disorders
NOT AVAILABLE"BIOTECH"
Goods and Servicesdevelopment of cell therapy products; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes; medical and pharmacological research services; medical research services; development of biotechnology; biotechnological research; cell separation research services; technological research in the field of cell therapy, medicine, pharmacology, biotechnology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 11, 2021
Primary Code005
First Use Anywhere DateTuesday, April 6, 2021
First Use In Commerce DateTuesday, April 6, 2021

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 11, 2021
Primary Code042
First Use Anywhere DateFriday, April 2, 2021
First Use In Commerce DateFriday, April 2, 2021

Trademark Owner History


Party NameNKGEN BIOTECH, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSANTA ANA, CA 92705

Party NameNKMAX CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGyeonggi-do 13605
KR

Party NameNKMAX CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGyeonggi-do 13605
KR

Party NameNKMAX CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGyeonggi-do 13605
KR

Trademark Events


Event DateEvent Description
Tuesday, February 9, 2021NEW APPLICATION ENTERED
Wednesday, March 24, 2021TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, March 24, 2021TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Tuesday, May 11, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 28, 2021ASSIGNED TO EXAMINER
Friday, September 10, 2021NON-FINAL ACTION WRITTEN
Friday, September 10, 2021NON-FINAL ACTION E-MAILED
Friday, September 10, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 11, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 12, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 21, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 20, 2022TEAS STATEMENT OF USE RECEIVED
Friday, May 20, 2022USE AMENDMENT FILED
Monday, June 6, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 7, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, July 14, 2022SU - NON-FINAL ACTION - WRITTEN
Thursday, July 14, 2022NON-FINAL ACTION E-MAILED
Thursday, July 14, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 21, 2022ASSIGNED TO LIE
Wednesday, September 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 13, 2022SU - FINAL REFUSAL - WRITTEN
Thursday, October 13, 2022FINAL REFUSAL E-MAILED
Thursday, October 13, 2022NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, November 16, 2022TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, November 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 9, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, December 10, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 17, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 17, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, October 4, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, December 6, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, December 6, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 6, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED